Biblio

Export 1756 results:
Author Title [ Type(Desc)] Year
Filters: First Letter Of Last Name is L  [Clear All Filters]
Journal Article
M. Sun, Zhao, Y., Han, M., Zhang, B., Zhang, X., Zhang, Q., Lim, N. K. - H., Wang, W. - A., and De Huang, F. -, “TTC7 and Hyccin Regulate Neuronal Aβ42 Accumulation and its Associated Neural Deficits in Aβ42-Expressing Drosophila.”, J Alzheimers Dis, vol. 65, no. 3, pp. 1001-1010, 2018.
C. Y. Liu, Ohki, Y., Tomita, T., Osawa, S., Reed, B. R., Jagust, W., Van Berlo, V., Jin, L. - W., Chui, H. C., Coppola, G., and Ringman, J. M., “Two Novel Mutations in the First Transmembrane Domain of Presenilin1 Cause Young-Onset Alzheimer's Disease.”, J Alzheimers Dis, vol. 58, no. 4, pp. 1035-1041, 2017.
F. Pasquier, Sadowsky, C., Holstein, A., Leterme, G. Le Prince, Peng, Y., Jackson, N., Fox, N. C., Ketter, N., Liu, E., and J Ryan, M., “Two Phase 2 Multiple Ascending-Dose Studies of Vanutide Cridificar (ACC-001) and QS-21 Adjuvant in Mild-to-Moderate Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1131-43, 2016.
F. Pasquier, Sadowsky, C., Holstein, A., Leterme, G. Le Prince, Peng, Y., Jackson, N., Fox, N. C., Ketter, N., Liu, E., and J Ryan, M., “Two Phase 2 Multiple Ascending-Dose Studies of Vanutide Cridificar (ACC-001) and QS-21 Adjuvant in Mild-to-Moderate Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1131-43, 2016.
S. Salloway, Sperling, R., Fox, N. C., Blennow, K., Klunk, W., Raskind, M., Sabbagh, M., Honig, L. S., Porsteinsson, A. P., Ferris, S., Reichert, M., Ketter, N., Nejadnik, B., Guenzler, V., Miloslavsky, M., Wang, D., Lu, Y., Lull, J., Tudor, I. Cristina, Liu, E., Grundman, M., Yuen, E., Black, R., and H Brashear, R., “Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.”, N Engl J Med, vol. 370, no. 4, pp. 322-33, 2014.
S. Salloway, Sperling, R., Fox, N. C., Blennow, K., Klunk, W., Raskind, M., Sabbagh, M., Honig, L. S., Porsteinsson, A. P., Ferris, S., Reichert, M., Ketter, N., Nejadnik, B., Guenzler, V., Miloslavsky, M., Wang, D., Lu, Y., Lull, J., Tudor, I. Cristina, Liu, E., Grundman, M., Yuen, E., Black, R., and H Brashear, R., “Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.”, N Engl J Med, vol. 370, no. 4, pp. 322-33, 2014.
S. Salloway, Sperling, R., Fox, N. C., Blennow, K., Klunk, W., Raskind, M., Sabbagh, M., Honig, L. S., Porsteinsson, A. P., Ferris, S., Reichert, M., Ketter, N., Nejadnik, B., Guenzler, V., Miloslavsky, M., Wang, D., Lu, Y., Lull, J., Tudor, I. Cristina, Liu, E., Grundman, M., Yuen, E., Black, R., and H Brashear, R., “Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.”, N Engl J Med, vol. 370, no. 4, pp. 322-33, 2014.
T. Rognoni, Fernández-Matarrubia, M., Martínez-González, M. Ángel, Salas-Salvadó, J., Corella, D., Castañer, O., J Martínez, A., Alonso-Gómez, Á. M., Gómez-Gracia, E., Vioque, J., Romaguera, D., López-Miranda, J., Estruch, R., Tinahones, F. J., Santos-Lozano, J. Manuel, Serra-Majem, L., Ibañez, N. Cano, Tur, J. A., Pérez, R. Micó, Pintó, X., Delgado-Rodríguez, M., Ramos, M. Ortiz, Martín, J. Vidal, Vázquez, C., Daimiel, L., Ros, E., Goñi-Ruiz, N., Babio, N., Sorlí, J. V., Schröder, H., García-Rios, A., Compañ-Gabucio, L., Warnberg, J., M Zulet, Á., Chaplin, A., Sacanella, E., Bouzalmate-Hajjaj, A., Tojal-Sierra, L., Damas-Fuentes, M., Vázquez, Z., Gómez-Martínez, C., Saiz, C., Malcampo, M., Ortiz-Morales, A. M., Martínez-Avilés, V., García-Gavilan, J., Abete, I., Fitó, M., and Toledo, E., “Two-Year Changes in Physical Activity and Concurrent Changes in Cognitive Function in a Cohort of Adults with Metabolic Syndrome.”, J Alzheimers Dis, vol. 95, no. 3, pp. 887-899, 2023.
W. Li, Huang, E., and Gao, S., “Type 1 Diabetes Mellitus and Cognitive Impairments: A Systematic Review.”, J Alzheimers Dis, vol. 57, no. 1, pp. 29-36, 2017.
M. Xie, Han, Y., Yu, Q., Wang, X., Wang, S., and Liao, X., “UCH-L1 Inhibition Decreases the Microtubule-Binding Function of Tau Protein.”, J Alzheimers Dis, vol. 49, no. 2, pp. 353-63, 2016.
E. Tuzzi, Balla, D. Z., Loureiro, J. R. A., Neumann, M., Laske, C., Pohmann, R., Preische, O., Scheffler, K., and Hagberg, G. E., “Ultra-High Field MRI in Alzheimer's Disease: Effective Transverse Relaxation Rate and Quantitative Susceptibility Mapping of Human Brain In Vivo and Ex Vivo Compared to Histology.”, J Alzheimers Dis, vol. 73, no. 4, pp. 1481-1499, 2020.
E. Tuzzi, Balla, D. Z., Loureiro, J. R. A., Neumann, M., Laske, C., Pohmann, R., Preische, O., Scheffler, K., and Hagberg, G. E., “Ultra-High Field MRI in Alzheimer's Disease: Effective Transverse Relaxation Rate and Quantitative Susceptibility Mapping of Human Brain In Vivo and Ex Vivo Compared to Histology.”, J Alzheimers Dis, vol. 73, no. 4, pp. 1481-1499, 2020.
A. Loughman, Adler, C. J., and Macpherson, H., “Unlocking Modifiable Risk Factors for Alzheimer's Disease: Does the Oral Microbiome Hold Some of the Keys?”, J Alzheimers Dis, vol. 92, no. 4, pp. 1111-1129, 2023.
B. Seok Ye, Jang, E. Young, Kim, S. Yoon, Kim, E. - J., Park, S. Ah, Lee, Y., Hong, C. Hyung, Choi, S. Hye, Yoon, B., Yoon, S. Jin, Na, H. Ri, Lee, J. - H., Jeong, J. H., Kim, H. Jin, Na, D. L., and Seo, S. Won, “Unstable Body Mass Index and Progression to Probable Alzheimer's Disease Dementia in Patients with Amnestic Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 49, no. 2, pp. 483-91, 2016.
B. Seok Ye, Jang, E. Young, Kim, S. Yoon, Kim, E. - J., Park, S. Ah, Lee, Y., Hong, C. Hyung, Choi, S. Hye, Yoon, B., Yoon, S. Jin, Na, H. Ri, Lee, J. - H., Jeong, J. H., Kim, H. Jin, Na, D. L., and Seo, S. Won, “Unstable Body Mass Index and Progression to Probable Alzheimer's Disease Dementia in Patients with Amnestic Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 49, no. 2, pp. 483-91, 2016.
C. M. Teixeira, Pallas-Bazarra, N., Bolós, M., Terreros-Roncal, J., Avila, J., and Llorens-Martín, M., “Untold New Beginnings: Adult Hippocampal Neurogenesis and Alzheimer's Disease.”, J Alzheimers Dis, vol. 64, no. s1, pp. S497-S505, 2018.
W. Li and Huang, E., “An Update on Type 2 Diabetes Mellitus as a Risk Factor for Dementia.”, J Alzheimers Dis, vol. 53, no. 2, pp. 393-402, 2016.
B. Garcia, Martin, C., Garcia-Suarez, O., Muniz-Alonso, B., Ordiales, H., Fernandez-Menendez, S., Santos-Juanes, J., Lorente-Gea, L., Castanon, S., Vicente-Etxenausia, I., Batista, K. Manuel Pin, Ruiz-Diaz, I., Caballero-Martinez, M. Cristina, Merayo-Lloves, J., Guerra-Merino, I., Quiros, L. M., and Fernandez-Vega, I., “Upregulated Expression of Heparanase and Heparanase 2 in the Brains of Alzheimer's Disease.”, J Alzheimers Dis, vol. 58, no. 1, pp. 185-192, 2017.
G. - H. Lee, Jang, B., Choi, H. - S., Kim, H. - J., Park, J. - H., Jeon, Y. - C., Carp, R. I., Kim, Y. - S., and Choi, E. - K., “Upregulation of Connexin 43 Expression Via C-Jun N-Terminal Kinase Signaling in Prion Disease.”, J Alzheimers Dis, vol. 49, no. 4, pp. 1005-19, 2016.
H. Zhang, D'Agostino, C., Forman, H. Jay, Cacciottolo, M., Thorwald, M., Mack, W. J., Liu, Q., Shkirkova, K., Lamorie-Foote, K., Sioutas, C., Pirhadi, M., Mack, W. Jean, Morgan, T. E., and Finch, C. E., “Urban Air Pollution Nanoparticles from Los Angeles: Recently Decreased Neurotoxicity.”, J Alzheimers Dis, vol. 82, no. 1, pp. 307-316, 2021.
H. Zhang, D'Agostino, C., Forman, H. Jay, Cacciottolo, M., Thorwald, M., Mack, W. J., Liu, Q., Shkirkova, K., Lamorie-Foote, K., Sioutas, C., Pirhadi, M., Mack, W. Jean, Morgan, T. E., and Finch, C. E., “Urban Air Pollution Nanoparticles from Los Angeles: Recently Decreased Neurotoxicity.”, J Alzheimers Dis, vol. 82, no. 1, pp. 307-316, 2021.
N. Zhang, Zhang, L., Li, Y., Gordon, M. L., Cai, L., Wang, Y., Xing, M., and Cheng, Y., “Urine AD7c-NTP Predicts Amyloid Deposition and Symptom of Agitation in Patients with Alzheimer's Disease and Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 60, no. 1, pp. 87-95, 2017.
Z. Tong, Wang, W., Luo, W., Lv, J., Li, H., Luo, H., Jia, J., and He, R., “Urine Formaldehyde Predicts Cognitive Impairment in Post-Stroke Dementia and Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1031-1038, 2017.
Z. Tong, Wang, W., Luo, W., Lv, J., Li, H., Luo, H., Jia, J., and He, R., “Urine Formaldehyde Predicts Cognitive Impairment in Post-Stroke Dementia and Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1031-1038, 2017.
Z. Tong, Wang, W., Luo, W., Lv, J., Li, H., Luo, H., Jia, J., and He, R., “Urine Formaldehyde Predicts Cognitive Impairment in Post-Stroke Dementia and Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1031-1038, 2017.

Pages